S&P 500

5.431,60

-0,04%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
OptimizeRx Corporation (OPRX)
OptimizeRx Corporation (OPRX) Notícias

OPRX

OptimizeRx (OPRX)

OptimizeRx Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:OPRX

1 2 3 4 5 6 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
11/06/2024	18:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OPRX	OptimizeRx Corporation
10/06/2024	10:00	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:OPRX	OptimizeRx Corporation
07/06/2024	17:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPRX	OptimizeRx Corporation
15/05/2024	18:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OPRX	OptimizeRx Corporation
06/05/2024	22:34	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:OPRX	OptimizeRx Corporation
14/02/2024	19:05	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:OPRX	OptimizeRx Corporation
09/01/2024	18:28	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:OPRX	OptimizeRx Corporation
05/01/2024	19:19	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:OPRX	OptimizeRx Corporation
30/10/2023	17:06	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:OPRX	OptimizeRx Corporation
20/06/2023	09:00	GlobeNewswire Inc.	LifeMD Appoints William J. Febbo to its Board of Directors	NASDAQ:OPRX	OptimizeRx Corporation
09/06/2023	17:32	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:OPRX	OptimizeRx Corporation
07/06/2023	17:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPRX	OptimizeRx Corporation
25/04/2023	17:29	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:OPRX	OptimizeRx Corporation
20/04/2023	16:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPRX	OptimizeRx Corporation
10/03/2023	18:57	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:OPRX	OptimizeRx Corporation
10/03/2023	18:53	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	NASDAQ:OPRX	OptimizeRx Corporation
10/03/2023	18:47	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:OPRX	OptimizeRx Corporation
03/03/2023	20:56	PR Newswire (US)	Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600	NASDAQ:OPRX	OptimizeRx Corporation
09/02/2023	13:53	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:OPRX	OptimizeRx Corporation
10/11/2022	22:49	TipRanks	OptimizeRx (OPRX) Receives a Buy from RBC Capital	NASDAQ:OPRX	OptimizeRx Corporation
10/11/2022	01:30	TipRanks	Analysts Offer Insights on Technology Companies: Activision Blizzard (ATVI), OptimizeRx (OPRX) and Embark Technology, Inc. (EMBK)	NASDAQ:OPRX	OptimizeRx Corporation
09/11/2022	12:25	TipRanks	OptimizeRx (OPRX) Gets a Buy from B.Riley Financial	NASDAQ:OPRX	OptimizeRx Corporation
08/11/2022	18:46	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:OPRX	OptimizeRx Corporation
03/10/2022	15:59	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:OPRX	OptimizeRx Corporation
14/09/2022	22:46	TipRanks	RBC Capital Keeps Their Buy Rating on OptimizeRx (OPRX)	NASDAQ:OPRX	OptimizeRx Corporation
19/08/2022	17:46	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:OPRX	OptimizeRx Corporation
10/08/2022	09:05	TipRanks	B.Riley Financial Sticks to Their Buy Rating for OptimizeRx (OPRX)	NASDAQ:OPRX	OptimizeRx Corporation
10/08/2022	09:01	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:OPRX	OptimizeRx Corporation
25/07/2022	11:13	TipRanks	Down More Than 50%: These 2 ‘Strong Buy’ Stocks Are Trading at Rock-Bottom Prices	NASDAQ:OPRX	OptimizeRx Corporation
20/07/2022	08:25	TipRanks	B.Riley Financial Remains a Buy on OptimizeRx (OPRX)	NASDAQ:OPRX	OptimizeRx Corporation